Clinical Commander

Back to dossier
peds.nec.v1PRODUCTION
peds.nec.v1

Necrotizing enterocolitis (NEC) — neonatal / preterm Bell-staged

pediatricsacuteneonatal
Hard-required inputs
0 / 22
Care setting:

Encounter flow

12/12 authored

Canonical 12-phase frame with authored status for this dossier.

Current phase

Frame

Detailed

Frame the preterm-NICU NEC presentation: gestational age + birth weight + chronologic age in days + onset relative to feeding-advance. Onset < day 7 + no pneumatosis + recent indomethacin/steroids → SIP suspicion (pivot to differential); onset week 2-4 in VLBW preterm post-feeding-advance → classic NEC pretest 7-10%; onset in term/late-preterm → atypical, broaden DDx (malrotation/volvulus, CHD with mesenteric ischemia, sepsis with translocation).

Inputs
3
Actions
0
Advance rule
Set
Advance when

NEC vs SIP vs broader-DDx framing set; gestational-age cohort tagged

Patient inputs (25)

Extreme preterm < 28 wk vs very preterm 28-32 wk vs late preterm 32-36 wk vs term ≥ 37 wk drives pretest probability + surgical decision (peritoneal drain vs laparotomy) + atypical-presentation broader DDx in term

VLBW < 1500 g and ELBW < 1000 g cohorts drive NEC pretest probability ~ 7-10%; weight-based dosing for all neonatal drugs; ELBW favours peritoneal drain over laparotomy in perforation

Bradycardia + apnoea episodes in Stage IIIA NEC; tachycardia in early NEC with dehydration

Apnoea / respiratory failure in Stage IIIA NEC drives ventilator-dependence

Hypoxaemia → intubation decision in advanced NEC

Mother's-own-milk vs donor-human-milk vs formula; standardised feeding protocol; recent feeding-advance episode drives NEC pretest probability

Recent indomethacin (PDA management) OR antenatal/postnatal steroids → SIP > NEC differential (Gordon 2007)

PICC / umbilical line / surgical drain + TPN > 5-7 d in preterm → candidemia risk (IDSA candidiasis 2016)

Prolonged empiric antibiotics > 5-7 d in preterm is a NEC risk factor (Cantey 2018 PMID 30172430 dose-response)

Onset < day 7 raises SIP suspicion (no pneumatosis + indomethacin/steroid exposure); onset week 2-4 is classic NEC; onset > 4 wk is uncommon classic NEC

WBC < 5K or > 20K + neutropenia + thrombocytopenia < 100K supports Stage IIB-III NEC; serial trend more informative than single value

Sepsis coinfection workup; ≥ 1 mL minimum per bottle (Schelonka 1996); positive culture at 36-48 h LR+ > 100

CRP > 10 mg/L LR+ ~ 3-5; serial 24 + 48 h pair more informative than single value; rising CRP despite ≥ 48 h antibiotics is a relative surgical indication

Metabolic acidosis (HCO3 < 18) supports Stage IIB; hyponatremia + hypoglycemia common; AKI marker (BUN / creatinine elevation)

Lactate > 4 mmol/L suggests perfusion failure / bowel ischaemia; serial trend for resuscitation response + surgical decision

Thrombocytopenia < 100K supports Stage IIB; declining trend raises Candida coinfection suspicion in TPN + broad-abx preterm

DIC in Stage IIIA NEC; INR / aPTT / fibrinogen / D-dimer baseline + serial

Metabolic acidosis severity + pCO2 + lactate; serial trend for resuscitation response

Stage I criterion: occult blood; bloody stools more advanced; differential includes allergic colitis + swallowed maternal blood in non-NEC

Serial KUB q6-12h for Bell-staging progression detection; AP + left-lateral-decubitus views; pneumatosis intestinalis LR+ ~ 50 for NEC; pneumoperitoneum essentially diagnostic of perforation; portal venous gas LR+ ~ 20; fixed loop > 24 h LR+ ~ 10 for progression

Hypothermia in preterm with NEC is concerning for sepsis coinfection; fever rare in NEC alone

Hypotension in Stage IIIA-B NEC (SBP < gestational-age threshold) drives vasoactive

Bedside US for free fluid + bowel-wall thickening + perfusion + portal venous gas; complementary to KUB; especially useful in extremely preterm / unstable infants

TPN + broad-abx + preterm + thrombocytopenia / persistent fever despite antibacterial cover → fungal cultures + 1,3-β-D-glucan if Candida coinfection suspected (IDSA candidiasis 2016)

Reserved for post-recovery stricture evaluation (~ 10-30% after Stage II-III medical); NOT acute NEC workup

* = hard-required. Engine cannot meaningfully run until these are filled.

Severity triggers (10)

10 need judgement
  • informationallife_threateningnec_stage_iiib_with_perforation
    Bell Stage IIIB — pneumoperitoneum on KUB (free air under diaphragm, football sign, Rigler sign) — life-threatening surgical emergency requiring emergent pediatric-surgery evaluation: peritoneal drain in extremely preterm < 1000 g vs laparotomy in larger; surgical resection of necrotic bowel ± ostomy formation; ICU + max support (Walsh & Kliegman 1986; AAP NEC guidance)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationallife_threateningnec_stage_iiia_severe_no_perforation
    Bell Stage IIIA — advanced NEC without overt perforation: ventilator-dependent + hypotension + bradycardia + severe apnoea + DIC + neutropenia — life-threatening systemic involvement; surgical readiness; aggressive antibiotic + supportive care; possible bowel resection without overt perforation (Walsh & Kliegman 1986; AAP NEC guidance)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationalseverenec_stage_ii_with_pneumatosis_intestinalis
    Bell Stage IIA or IIB — definite NEC with pneumatosis intestinalis on KUB (pathognomonic; LR+ ~ 50 for NEC). IIB adds metabolic acidosis + thrombocytopenia. Severe; full antibiotic course (7-10 d) + NPO 7-14 d + serial KUB + nutrition planning + surgical-readiness in IIB (Walsh & Kliegman 1986; AAP NEC guidance)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationalseverenec_with_portal_venous_gas
    Portal venous gas on KUB or abdominal US (LR+ ~ 20 for NEC) — relative surgical indication; high mortality if delayed surgical evaluation; consider exploration even without overt free air (Pediatric Radiology imaging literature)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationalseverenec_in_term_or_late_preterm_infant_atypical
    NEC in term or late-preterm infant (≥ 32 wk) is atypical (~ 0.1% of NICU admissions vs ~ 7-10% in VLBW) — consider underlying anomaly: malrotation/volvulus (upper-GI series), congenital heart disease with mesenteric ischemia (echo + cardiology), sepsis with bacterial translocation (full sepsis workup), Hirschsprung-associated enterocolitis (history of delayed meconium passage). Broader differential workup beyond standard preterm-NEC pathway
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationalsevererecurrent_nec_post_initial_resolution
    Recurrent NEC after initial antibiotic course + Bell-staging resolution — repeat workup with KUB + abdominal exam + CBC + CRP + blood culture; consider stricture (~ 10-30% after Stage II-III medical), missed perforation, or post-NEC mucosal injury; long-term peds-GI + peds-surgery follow-up
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationalseverenec_with_short_bowel_syndrome_emerging
    Extensive surgical resection (> 50% small bowel) + early TPN-dependence → short bowel syndrome emerging → nutrition consult + central venous access + long-term IFALD prevention (lipid strategy modification, minimise TPN duration, advance enteral feeds early); intestinal transplant evaluation if non-rehabilitatable (Pichler 2014; ASPEN guidelines)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationalseverenec_stricture_post_medical_management
    Feeding intolerance + abdominal distention + bilious emesis post-recovery from Stage II-III medical NEC — stricture incidence ~ 10-30%; contrast study (upper-GI or lower-GI per location) + peds-GI + peds-surgery → surgical resection of stricture (Pediatric Surgery NEC-stricture literature)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationalmoderatesip_vs_nec_differential_clarification
    Early-onset perforation < day 7 + no pneumatosis intestinalis on KUB + recent indomethacin or steroid exposure (PDA management OR antenatal/postnatal corticosteroids) — spontaneous intestinal perforation (SIP) more likely than NEC; SIP management differs (often peritoneal drain-then-watch; less aggressive antibiotic course) (Gordon 2007 SIP literature; Pediatric Surgery 2024 SIP-vs-NEC consensus)
    Trigger could not be auto-evaluated — needs clinician judgement.
  • informationalmoderatehuman_milk_feeding_protocol_prevention_eligible
    VLBW infant in prevention pathway — mother's-own-milk preferred OR donor human milk; standardised feeding protocol; reduces NEC ~ 50% vs formula (Quigley & McGuire Cochrane 2019); supplementary lactoferrin (Pammi & Suresh Cochrane 2020); probiotic supplementation (Bifidobacterium + Lactobacillus) per ESPGHAN 2020 with caveats (regulatory caution in US per occasional contamination signals)
    Trigger could not be auto-evaluated — needs clinician judgement.

Workflow calculators

Run this disease's risk and dosing calculators inline.

TREATMENToptionalDrives dose adjustment
Loading…

Recommended regimen

NEC empiric antibiotics — by Bell stage + comorbidity (Walsh & Kliegman 1986; AAP NEC guidance; Cantey 2018 stewardship)
axis: nec_empirics_by_bell_stagestep stage_i_ii_medical - Stage I-II medical management — cover Gram-positive, Gram-negative, anaerobe
Selected step "Stage I-II medical management — cover Gram-positive, Gram-negative, anaerobe" — Bell Stage I (suspected) or Stage II (definite, pneumatosis intestinalis on KUB) without perforation or extreme systemic deterioration
  • ampicillin
    first line
    aminopenicillin
    200 mg/kg/day divided q8h (DOL 0-7) or q6h (DOL > 7); meningitis dose: 300 mg/kg/day divided q6-8h • IV • q6-8h
    triggers: nec_stage_i_or_ii_recognition
    Covers Gram-positive (including Listeria) + sensitive E. coli baseline; standard NEC empiric (AAP NEC guidance)
    rxcui 733
  • gentamicin
    first line
    aminoglycoside
    Term ≥ 35 wk: 4 mg/kg q24h; late-preterm 30-34 wk: 4.5 mg/kg q36h; preterm < 30 wk: 5 mg/kg q48h (extended interval per gestational age) • IV • q24-48h extended interval
    triggers: nec_stage_i_or_ii_recognition, gram_negative_synergy_with_ampicillin
    Gram-negative synergy with ampicillin; extended-interval dosing per Neofax + AAP Puopolo 2018; trough monitoring before 3rd dose
    rxcui 1596450
  • metronidazole
    add on
    nitroimidazole
    15 mg/kg load then 7.5 mg/kg q12h (DOL > 7) or q24h (DOL < 7) • IV • q12-24h
    triggers: nec_stage_ii_with_pneumatosis_intestinalis, intra_abdominal_anaerobe_concern
    Anaerobic cover for confirmed NEC (Stage II+) where bowel-wall integrity is compromised; alternative pip-tazo combined regimen if preferred
    rxcui 6922
  • piperacillin-tazobactam
    comorbidity specific
    penicillin_BLI
    80-100 mg/kg/dose (piperacillin component) IV q6-8h (gestational + chronological-age dependent) • IV • q6-8h
    triggers: nec_stage_ii_alternative_to_amp_gent_metro, recent_broad_abx_mdro_risk
    Anaerobe + Pseudomonas + enteric Gram-negative cover; alternative to ampicillin + gentamicin + metronidazole combo; single agent simplifies regimen
    rxcui 74169
  • vancomycin
    add on
    glycopeptide
    15 mg/kg/dose IV; interval per gestational + chronological age (q6h-q18h) • IV • per nomogram
    triggers: mrsa_risk, cons_risk_central_line, severe_nec_with_line_source
    Add-on for MRSA / CoNS / line-associated sepsis coinfection; AUC target 400-600 (Rybak IDSA 2020) with caveat — limited neonatal data
    rxcui 11124

outpatient playbook — drug actions (5)

  1. 1. IV-to-PO antibiotic continuation if course ongoing at discharge
    Pathogen-specific PO step-down (rare in neonate) • PO • per agent
    trigger: Discharge with antibiotic course incomplete (rare in neonate; most NEC courses complete inpatient)
    Most neonatal courses complete inpatient; rare outpatient continuation
  2. 2. iron supplementation per WHO + AAP
    2-4 mg/kg/day elemental iron PO from age 1 mo (preterm) or 4 mo (term) • PO • daily
    trigger: Anemia of prematurity post-NEC; standard preterm supplementation
    AAP iron supplementation guidelines for preterm + NEC survivors
  3. 3. vitamin D + multivitamin per AAP
    400 IU/day vitamin D + standard preterm multivitamin • PO • daily
    trigger: Standard preterm supplementation
    AAP preterm nutrition guidelines
  4. 4. PCV15 or PCV20 + Hib at age-appropriate timing
    Per ACIP age-based schedule • IM • per ACIP
    trigger: Age 2 months (after neonatal period ends)
    AAP Red Book 2024 + ACIP standard schedule; NEC history does not modify schedule
  5. 5. influenza + COVID-19 vaccines for family contacts
    Per ACIP age-based schedule • IM • annual / per ACIP
    trigger: Every post-NEC follow-up visit during season for family contacts
    Reduce future respiratory-source sepsis risk + protect neonate via cocooning

Auto-drafted A&P note

outpatient

Subjective

- Possible entry pathways: Preterm neonate with feeding intolerance (residuals, emesis), abdominal distention, occult/bloody stools (Walsh & Kliegman 1986; AAP NEC guidance); Preterm neonate with abdominal wall erythema / induration / palpable mass — advanced NEC (Stage IIB+) features; Preterm neonate with declining platelets + metabolic acidosis (Stage IIB criteria; Walsh & Kliegman 1986).

Objective

- No vitals, labs, or imaging entered for this encounter.

Assessment

**Necrotizing enterocolitis (NEC) — neonatal / preterm Bell-staged** (peds.nec.v1).
Phenotype framing: Spontaneous intestinal perforation (SIP) — early < day 7 + no pneumatosis + indomethacin/steroid exposure (Gordon 2007 pivot). NEC in term infant → broader DDx (malrotation/volvulus → upper GI series; congenital heart disease with mesenteric ischemia → echo; sepsis with bacterial translocation). Hirschsprung-associated enterocolitis (history of delayed meconium passage). Allergic enterocolitis (milk-protein-induced). Volvulus / intussusception (late-preterm and term). Coexistence pairs: NEC + sepsis (most cases); NEC + AKI; NEC + DIC; NEC + Candidemia.
Scope: Frame the preterm-NICU NEC presentation: gestational age + birth weight + chronologic age in days + onset relative to feeding-advance. Onset < day 7 + no pneumatosis + recent indomethacin/steroids → SIP suspicion (pivot to differential); onset week 2-4 in VLBW preterm post-feeding-advance → classic NEC pretest 7-10%; onset in term/late-preterm → atypical, broaden DDx (malrotation/volvulus, CHD with mesenteric ischemia, sepsis with translocation).

No severity triggers fired against current inputs.

Plan

Regimen axis: **NEC empiric antibiotics — by Bell stage + comorbidity (Walsh & Kliegman 1986; AAP NEC guidance; Cantey 2018 stewardship)** — step "Stage I-II medical management — cover Gram-positive, Gram-negative, anaerobe".
1. ampicillin 200 mg/kg/day divided q8h (DOL 0-7) or q6h (DOL > 7); meningitis dose: 300 mg/kg/day divided q6-8h IV q6-8h (aminopenicillin, first line) — Covers Gram-positive (including Listeria) + sensitive E. coli baseline; standard NEC empiric (AAP NEC guidance)
2. gentamicin Term ≥ 35 wk: 4 mg/kg q24h; late-preterm 30-34 wk: 4.5 mg/kg q36h; preterm < 30 wk: 5 mg/kg q48h (extended interval per gestational age) IV q24-48h extended interval (aminoglycoside, first line) — Gram-negative synergy with ampicillin; extended-interval dosing per Neofax + AAP Puopolo 2018; trough monitoring before 3rd dose
3. metronidazole 15 mg/kg load then 7.5 mg/kg q12h (DOL > 7) or q24h (DOL < 7) IV q12-24h (nitroimidazole, add on) — Anaerobic cover for confirmed NEC (Stage II+) where bowel-wall integrity is compromised; alternative pip-tazo combined regimen if preferred
4. piperacillin-tazobactam 80-100 mg/kg/dose (piperacillin component) IV q6-8h (gestational + chronological-age dependent) IV q6-8h (penicillin_BLI, comorbidity specific) — Anaerobe + Pseudomonas + enteric Gram-negative cover; alternative to ampicillin + gentamicin + metronidazole combo; single agent simplifies regimen
5. vancomycin 15 mg/kg/dose IV; interval per gestational + chronological age (q6h-q18h) IV per nomogram (glycopeptide, add on) — Add-on for MRSA / CoNS / line-associated sepsis coinfection; AUC target 400-600 (Rybak IDSA 2020) with caveat — limited neonatal data

Setting playbook (outpatient) — Post-discharge primary-care + peds-GI + peds-surgery + nutrition + neurodevelopmental follow-up. High-risk NEC survivors need close surveillance for stricture (~ 10-30%), SBS / IFALD (if extensive resection), neurodevelopmental sequelae (preterm + NEC at elevated risk), and recurrent feeding intolerance
6. IV-to-PO antibiotic continuation if course ongoing at discharge Pathogen-specific PO step-down (rare in neonate) PO per agent — Discharge with antibiotic course incomplete (rare in neonate; most NEC courses complete inpatient) (Most neonatal courses complete inpatient; rare outpatient continuation)
7. iron supplementation per WHO + AAP 2-4 mg/kg/day elemental iron PO from age 1 mo (preterm) or 4 mo (term) PO daily — Anemia of prematurity post-NEC; standard preterm supplementation (AAP iron supplementation guidelines for preterm + NEC survivors)
8. vitamin D + multivitamin per AAP 400 IU/day vitamin D + standard preterm multivitamin PO daily — Standard preterm supplementation (AAP preterm nutrition guidelines)
9. PCV15 or PCV20 + Hib at age-appropriate timing Per ACIP age-based schedule IM per ACIP — Age 2 months (after neonatal period ends) (AAP Red Book 2024 + ACIP standard schedule; NEC history does not modify schedule)
10. influenza + COVID-19 vaccines for family contacts Per ACIP age-based schedule IM annual / per ACIP — Every post-NEC follow-up visit during season for family contacts (Reduce future respiratory-source sepsis risk + protect neonate via cocooning)

Non-pharmacologic actions:
- Physical therapy referral if functional decline / muscle tone abnormalities (especially preterm)
- Occupational therapy referral if fine-motor / ADL development concerns
- Speech / language therapy if speech delay OR dysphagia
- Developmental peds referral if Bayley / ASQ delays > 1 SD below mean
- Lactation continued support if breastfeeding
- Family adherence support + psychosocial barrier identification + social work if resource gaps
- Family CPR / infant safety + return precautions reinforcement
- Ostomy nurse follow-up + ostomy care reinforcement if applicable
- Nutrition follow-up for feeding-advance protocol + SBS / IFALD management if applicable

AVOID / contraindication checks:
- Ceftriaxone avoid under 28 days bilirubin displacement calcium ivf (AAP Puopolo 2018; FDA 2009)
- Gentamicin extended interval by gestational age neonate (AAP Puopolo 2018; Neofax)
- Fluoroquinolone avoid neonate unless no alternative (AAP Red Book 2024)
- Vancomycin AUC target not trough (Rybak IDSA 2020 PMID 32191793 with caveat — limited neonatal calibration)
- Enteral feeding hold during active NEC (Walsh & Kliegman 1986; AAP NEC guidance — bowel rest 7 14 d in Stage II; longer in Stage III with surgical resection)
- Dopamine vs epinephrine neonatal shock individualized (Subhedar Cochrane neonatal vasopressor reviews)
- Fluid bolus 10 to 20 mL per kg slower in neonate (AAP neonatal specific adaptation of SSC peds 2020)

Monitoring

Regimen monitoring:
- CBC + CRP + platelets at 24 + 48 h (serial trend more informative than single value in neonate)
- blood culture follow-up at 24 + 48 h
- gentamicin trough before 3rd dose target < 2 mcg/mL (Neofax)
- vancomycin AUC q48-72h (or trough if AUC unavailable, target 15-20)
- serial KUB q6-12h during acute phase for Bell-stage progression detection
- abdominal girth q4h + NG output + stool output + emesis q4h
- lactate q2-4h until clearance
- daily reassessment of antibiotic + duration with goal de-escalation per Cantey 2018 stewardship
- rising CRP despite ≥ 48 h antibiotics → relative surgical indication; pediatric surgery reassessment

Setting (outpatient) monitoring:
- Peds visit at 24-48 h, 1 wk, 1 mo, 3 mo, 6 mo, 12 mo, then per standard schedule
- Peds-GI at 1-3 mo + 6 mo + as needed for stricture surveillance
- Peds-surgery at 2-4 wk + 6-12 wk for ostomy takedown if applicable
- Nutrition q1-3 mo for TPN-dependent / SBS
- Neurodevelopmental re-assessment at 6 mo + 12 mo + 24 mo (preterm + NEC at elevated risk)
- Family mental health re-screen at 3 mo + 6 mo + 12 mo
- Immunization status audit at every visit until catch-up complete

Follow-up plan: Outpatient peds within 24-48 h of discharge for high-risk; 1-week visit for all; growth + feeding tracking + developmental milestones; peds-GI surveillance for stricture (~ 10-30% after Stage II-III medical; symptoms — feeding intolerance, distention, emesis post-recovery; contrast study + surgical resection if symptomatic stricture); peds-surgery follow-up for post-op (ostomy management, takedown timing); nutrition follow-up for SBS / IFALD if extensive resection (TPN management, lipid strategy, central line care, intestinal transplant evaluation if non-rehabilitatable); neurodevelopmental peds at 6 + 12 + 24 mo (Bayley III / ASQ-3 — preterm + NEC survivors at elevated risk); immunization catch-up per cause (PCV / Hib + hepatitis B); hearing screen if meningitis precipitant. Family education on return precautions; vaccination of family contacts (Tdap, influenza, COVID-19); breastfeeding support.
- Close-out criterion: Outpatient plan documented; peds-GI + peds-surgery + nutrition + neurodev follow-up scheduled; family education delivered

Monitoring phase: Vitals q4h (q1h initially in ill neonate), abdominal girth q4h, NG output + stool output + emesis q4h, weight daily, lactate trend q2-4h until normalised, CBC + CRP + platelets at 24 + 48 h, blood culture follow-up at 24 + 48 h, vancomycin / gentamicin levels per pharmacy (trough or AUC), serial KUB q6-12h during acute phase, daily reassessment of antibiotic + duration with goal de-escalation per Cantey 2018 stewardship; nutrition + feeding-advance plan; developmental + feeding follow-up.

Disposition

Current setting: outpatient — Post-discharge primary-care + peds-GI + peds-surgery + nutrition + neurodevelopmental follow-up. High-risk NEC survivors need close surveillance for stricture (~ 10-30%), SBS / IFALD (if extensive resection), neurodevelopmental sequelae (preterm + NEC at elevated risk), and recurrent feeding intolerance

Disposition criteria:
- Sustained recovery — growth at age-appropriate baseline, neurodevelopmental assessments within age-appropriate range, immunization catch-up complete, family demonstrating return-precaution knowledge + ostomy care if applicable, no recurrent NEC in 12 mo, no symptomatic stricture

Escalation triggers (move to higher acuity):
- New abdominal distention + bilious emesis + feeding intolerance post-recovery → urgent peds-GI + peds-surgery + contrast study for stricture
- New fever > 38 °C OR recurrent symptoms within 4 weeks of discharge → return to ED, blood culture, source-directed workup
- New focal neurological signs OR seizures → urgent neuro + neuroimaging
- Hearing loss confirmed on audiology → ENT + audiology + speech + early intervention
- TPN-associated cholestasis worsening (direct bilirubin > 2 sustained) → lipid strategy modification + intestinal transplant evaluation
- Family caregiver PHQ-9 ≥ 15 OR EPDS elevated → mental-health urgent referral
- Suspected immunodeficiency (≥ 2 serious infections in 12 mo OR unusual pathogen recurrence) → clinical immunology referral

Earlier-Return Triggers

Return-precaution thresholds (watch for):
- [LIFE_THREATENING] Bell Stage IIIB — pneumoperitoneum on KUB (free air under diaphragm, football sign, Rigler sign) — life-threatening surgical emergency requiring emergent pediatric-surgery evaluation: peritoneal drain in extremely preterm < 1000 g vs laparotomy in larger; surgical resection of necrotic bowel ± ostomy formation; ICU + max support (Walsh & Kliegman 1986; AAP NEC guidance)
- [LIFE_THREATENING] Bell Stage IIIA — advanced NEC without overt perforation: ventilator-dependent + hypotension + bradycardia + severe apnoea + DIC + neutropenia — life-threatening systemic involvement; surgical readiness; aggressive antibiotic + supportive care; possible bowel resection without overt perforation (Walsh & Kliegman 1986; AAP NEC guidance)
- [SEVERE] Bell Stage IIA or IIB — definite NEC with pneumatosis intestinalis on KUB (pathognomonic; LR+ ~ 50 for NEC). IIB adds metabolic acidosis + thrombocytopenia. Severe; full antibiotic course (7-10 d) + NPO 7-14 d + serial KUB + nutrition planning + surgical-readiness in IIB (Walsh & Kliegman 1986; AAP NEC guidance)

Citations

- Walsh & Kliegman 1986 Modified Bell Staging (Pediatr Clin North Am) + Bell 1978 original (Ann Surg) + AAP Section on Neonatal-Perinatal Medicine + Section on Surgery NEC clinical guidance + JNPM 2024 NEC update + Cantey 2018 antibiotic stewardship (PMID 30172430) + IDSA candidiasis 2016 (Pappas) + IDSA CRBSI 2009 (Mermel) + IDSA intra-abdominal 2010 (Solomkin) + Quigley & McGuire Cochrane 2019 (human milk vs formula) + Pammi & Suresh Cochrane 2020 (lactoferrin) + Gordon 2007 SIP-vs-NEC + Pediatric Surgery 2024 SIP-vs-NEC consensus [PMID:30172430](https://pubmed.ncbi.nlm.nih.gov/30172430/)
- Cited evidence (PMID 27452782) [PMID:27452782](https://pubmed.ncbi.nlm.nih.gov/27452782/)
- Cited evidence (PMID 25607427) [PMID:25607427](https://pubmed.ncbi.nlm.nih.gov/25607427/)
- Cited evidence (PMID 30455342) [PMID:30455342](https://pubmed.ncbi.nlm.nih.gov/30455342/)
- Cited evidence (PMID 30455344) [PMID:30455344](https://pubmed.ncbi.nlm.nih.gov/30455344/)

Last reconciled with current guidelines: 2026-05-15.
References
  • Walsh & Kliegman 1986 Modified Bell Staging (Pediatr Clin North Am) + Bell 1978 original (Ann Surg) + AAP Section on Neonatal-Perinatal Medicine + Section on Surgery NEC clinical guidance + JNPM 2024 NEC update + Cantey 2018 antibiotic stewardship (PMID 30172430) + IDSA candidiasis 2016 (Pappas) + IDSA CRBSI 2009 (Mermel) + IDSA intra-abdominal 2010 (Solomkin) + Quigley & McGuire Cochrane 2019 (human milk vs formula) + Pammi & Suresh Cochrane 2020 (lactoferrin) + Gordon 2007 SIP-vs-NEC + Pediatric Surgery 2024 SIP-vs-NEC consensus — PMID:30172430
  • Cited evidence (PMID 27452782) — PMID:27452782
  • Cited evidence (PMID 25607427) — PMID:25607427
  • Cited evidence (PMID 30455342) — PMID:30455342
  • Cited evidence (PMID 30455344) — PMID:30455344